Digital Insomnia Therapeutics Market Study Explores Industry Growth Toward $4.69 Billion

The digital insomnia therapeutics market is poised for remarkable growth as technological advances and increasing awareness about sleep health drive demand for innovative treatment options. With a growing preference for non-drug approaches, the market is evolving rapidly and offering promising solutions for people coping with chronic insomnia. Let's explore the current market size, key industry players, emerging trends, and detailed segmentation within this dynamic field.

Projected Market Size and Growth Forecast for Digital Insomnia Therapeutics
The market for digital insomnia therapeutics is set to expand significantly over the coming years, reaching a valuation of $4.7 billion by 2030. This growth corresponds to a compound annual growth rate (CAGR) of 6.1%. Several factors contribute to this upward trajectory, including the increasing clinical validation of digital therapies, integration of data from wearable devices, a rising preference for drug-free treatment methods, advancements in AI-powered sleep analytics, and the broadening reach of telehealth services. Key trends shaping the future include greater adoption of digital cognitive behavioral therapy for insomnia (CBT-I) programs, rising usage of sleep tracking apps, the growth of non-pharmacological sleep treatments, expansion of app-based insomnia management platforms, and deeper integration of wearables for monitoring sleep patterns.

The digital insomnia therapeutics market size has grown strongly in recent years. It will grow from $3.48 billion in 2025 to $3.7 billion in 2026 at a compound annual growth rate (CAGR) of 6.4%. The growth in the historic period can be attributed to high prevalence of sleep disorders, limitations of sleep medications, early digital health adoption, increasing mental health awareness, smartphone-based therapy growth.

Download a free sample of the digital insomnia therapeutics market report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=20750&type=smp&utm_source=OpenPR&utm_medium=Paid&utm_campaign=Aug_PR

Leading Companies Shaping the Digital Insomnia Therapeutics Sector
The digital insomnia therapeutics industry is dominated by a variety of influential firms such as Pear Therapeutics Inc., Calm.com Inc., Headspace Inc., Big Health Inc., Click Therapeutics Inc., Silvercloud Health Limited, OPTT Inc., Bodymatter Inc., SleepCogni Limited, Stellar Sleep, SleepScore Labs, Sliiip, SUSMED Inc., HelloBetter, AIMMED, Sleepstation (Born Digital Health), NOCTEM Health, Somryst, BetterNight, Minddistrict, Sleep Reset, SleepSpace, Black Dog Institute (Sleep Ninja), Insomnia-Coach, CBT-i Coach, ZenSleep, DrLullaby, and Night Owl Sleep Coach.

Significant Industry Moves Enhancing Market Capabilities
In June 2023, Nox Health Inc., a US-based company specializing in sleep diagnostics and value-based sleep care management, acquired Somryst in a deal with undisclosed financial details. This acquisition grants Nox Health access to Somryst's FDA-cleared digital insomnia therapeutic program along with its clinically supported CBT-I technology. As a result, Nox Health is now better positioned to enhance its digital sleep care offerings and broaden operational scale, reaching a larger patient base. Notably, Somryst holds the distinction of being the first FDA-cleared prescription digital therapeutic specifically designed for chronic insomnia.

View the full digital insomnia therapeutics market report:
https://www.thebusinessresearchcompany.com/report/digital-insomnia-therapeutics-global-market-report?utm_source=OpenPR&utm_medium=Paid&utm_campaign=Aug_PR

Emerging Trends Highlighting Technological Innovation in Digital Insomnia Therapeutics
Leading players in the digital insomnia therapeutics market are prioritizing the development of advanced software-based mobile apps that offer personalized, accessible, and affordable treatment solutions for insomnia management. These apps typically include features such as sleep pattern tracking, relaxation techniques, cognitive behavioral therapy modules, and tailored sleep advice.
For example, in August 2024, Big Health Inc., a US mental health services provider, secured FDA approval for SleepioRx, a digital therapeutic aimed at treating chronic insomnia in adults as an adjunct to standard care. SleepioRx delivers evidence-based interventions targeting cognitive and behavioral factors that contribute to persistent insomnia, supporting improved sleep outcomes for adults over 18 years of age.

Detailed Segment Analysis of the Digital Insomnia Therapeutics Market
This market is categorized by type, distribution channel, and application for a comprehensive understanding:
1) By Type: Sleep Tracking Apps, Relaxation and Meditation Apps, Cognitive-Behavioral Therapy for Insomnia (CBT-I), Wearable Devices, Other Types
2) By Distribution Channel: Hospital Pharmacies, Retail Pharmacies, Other Distribution Channels
3) By Application: Medical, Household

Further breakdown of segments includes:
- Sleep Tracking Apps consisting of Basic Sleep Monitoring Apps, Advanced Sleep Monitoring Apps, and Smart Alarm Apps
- Relaxation and Meditation Apps divided into Guided Meditation Apps, Breathing Exercise Apps, and Sleep-Inducing Music Apps
- Cognitive-Behavioral Therapy for Insomnia (CBT-I) encompassing Digital CBT-I Programs, CBT-I Mobile Apps, and Online CBT-I Therapy Platforms
- Wearable Devices covering Sleep-Tracking Wearables, Smartwatches with Sleep Tracking, and Wearables with Biofeedback for Insomnia
- Other Types including Virtual Reality (VR) Therapy for Insomnia, Biofeedback Devices, and Transcranial Magnetic Stimulation (TMS) Devices for Sleep

This detailed segmentation helps to capture the diversity and innovation present within the digital insomnia therapeutics market, highlighting its potential to cater to various patient needs and preferences.

What's included in our 2026 market reports:

• Market attractiveness scoring and analysis
• Total addressable market (TAM) analysis
• Company scoring matrix graphics and tables
• Excel-based forecasting dashboards
• Market hotspots infographics
• Key technologies and future trend analysis
• Updated graphics and tables

Reach out to us:
The Business Research Company: https://www.thebusinessresearchcompany.com/,
Americas +1 310-496-7795,
Europe +44 7882 955267,
Asia & Others +44 7882 955267 & +91 8897263534,
Email us at info@tbrc.info.

Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Learn More About The Business Research Company
With over 17500+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead.Our flagship product, the Global Market Model (GMM), is a premier market intelligence platform delivering comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.